Objective: To examine the conception rate after cessation of a combination of 30 mu g ethinyl E-2 and 2 mg dienogest (EE/DNG). Design: Prospective observational study. Setting: Population-based cohort in Germany. Patient(s): Women who wished to become pregnant after cessation of an oral contraceptive (EE/DNG). Intervention(s): None. Main Outcome Measure(s): Cumulative conception rate within 1 year after termination of EE/DNG and time to pregnancy. Result(s): After 1 year follow-up, the cumulative pregnancy rate was 86.6% (full analysis set; n = 706). When all participants with complete data were analyzed (n = 652), the cumulative pregnancy rate was 94.0%. More than 15% of the patients conceived in each of the first three cycles after termination of EE/DNG; the mean time to pregnancy was 3.5 cycles. The preceeding duration of treatment with EE/DNG did not influence the conception rate. Except in the youngest age group (16-18 years), a certain delay was observed in the other age groups. Conclusion(s): The present prospective study revealed only a slight delay in regaining fertility during the first three cycles after cessation of EE/DNG. Thereafter, the cumulative rate of conception did not differ form that observed in fertile women who attempted to become pregnant without prior conception.